JP2014521649A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521649A5
JP2014521649A5 JP2014522919A JP2014522919A JP2014521649A5 JP 2014521649 A5 JP2014521649 A5 JP 2014521649A5 JP 2014522919 A JP2014522919 A JP 2014522919A JP 2014522919 A JP2014522919 A JP 2014522919A JP 2014521649 A5 JP2014521649 A5 JP 2014521649A5
Authority
JP
Japan
Prior art keywords
composition
wound
pharmaceutically acceptable
salts
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014522919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014521649A (ja
JP6133858B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/047786 external-priority patent/WO2013016255A1/en
Publication of JP2014521649A publication Critical patent/JP2014521649A/ja
Publication of JP2014521649A5 publication Critical patent/JP2014521649A5/ja
Application granted granted Critical
Publication of JP6133858B2 publication Critical patent/JP6133858B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014522919A 2011-07-28 2012-07-23 創傷治癒組成物及び使用方法 Expired - Fee Related JP6133858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161512655P 2011-07-28 2011-07-28
US61/512,655 2011-07-28
PCT/US2012/047786 WO2013016255A1 (en) 2011-07-28 2012-07-23 Wound-healing compositions and method of use

Publications (3)

Publication Number Publication Date
JP2014521649A JP2014521649A (ja) 2014-08-28
JP2014521649A5 true JP2014521649A5 (enExample) 2015-09-10
JP6133858B2 JP6133858B2 (ja) 2017-05-24

Family

ID=46601927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014522919A Expired - Fee Related JP6133858B2 (ja) 2011-07-28 2012-07-23 創傷治癒組成物及び使用方法

Country Status (4)

Country Link
US (2) US20140194803A1 (enExample)
EP (1) EP2736486B1 (enExample)
JP (1) JP6133858B2 (enExample)
WO (1) WO2013016255A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202014100305U1 (de) * 2013-12-23 2015-04-20 Nawa-Heilmittel Gmbh Transparentes Gel
US9848604B2 (en) 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
CN107073161B (zh) * 2014-10-01 2020-11-03 3M创新有限公司 用于清创术的多孔装置、套件和方法
US20160101166A1 (en) * 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
US9592280B2 (en) * 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
WO2016089731A1 (en) * 2014-12-04 2016-06-09 3M Innovative Properties Company Antimicrobial compositions comprising bioglass
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
US10264788B2 (en) * 2015-12-30 2019-04-23 Carefusion 2200, Inc. Antimicrobial wipe
EP4487876A1 (en) 2023-07-07 2025-01-08 Leibniz-Institut für Polymerforschung Dresden e.V. Improved wound dressing and method to prepare it

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
US5080900A (en) 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash
US7014870B1 (en) 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AU700019B2 (en) * 1992-11-06 1998-12-17 Greystone Medical Group, Inc. Compositions of oak bark extract, related synthetic compositions, and method of using same
US7923469B2 (en) * 2001-04-30 2011-04-12 Allergen, Inc. Compositions including vitamin-based surfactants and methods for using same
AU2002359529B2 (en) * 2001-11-29 2008-02-21 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
CN102309473A (zh) * 2003-07-17 2012-01-11 纽约市哥伦比亚大学托管会 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物
US20050249818A1 (en) * 2004-05-03 2005-11-10 Sawan Samuel P Polycationic antimicrobial therapeutic
US20050249791A1 (en) * 2004-05-07 2005-11-10 3M Innovative Properties Company Antimicrobial articles
JP2008528595A (ja) * 2005-01-28 2008-07-31 ザ プロクター アンド ギャンブル カンパニー 液体溶媒中における分散粒子としてのジヨードメチル−ｐ−トリルスルホン
JP2009514884A (ja) * 2005-11-04 2009-04-09 イーストマン ケミカル カンパニー 難溶性医薬活性剤の投与のためのカルボキシアルキルセルロースエステル
DE102006001954B4 (de) * 2006-01-16 2013-01-03 Lohmann & Rauscher Gmbh & Co. Kg Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
WO2007143586A2 (en) * 2006-06-01 2007-12-13 Pharmaionx, Inc. Composition for wound care and method of using same
AU2008335083A1 (en) * 2007-12-11 2009-06-18 Stephen H. Monroe Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same

Similar Documents

Publication Publication Date Title
JP2014521649A5 (enExample)
JP2015528502A5 (enExample)
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
MX2014008020A (es) Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.
UA114888C2 (uk) Шипуча композиція у твердій формі для використання у вагінальних аплікаціях для лікування вагінальних інфекцій
JP2014530840A5 (enExample)
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
UA108623C2 (uk) Низьколеткі амінні солі аніонних пестицидів
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
CL2013002504A1 (es) Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion
JP2014509938A5 (enExample)
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2012014060A (es) Sistema de suministro de ingredientes activos.
CL2014002757A1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.
CL2014000468A1 (es) Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana.
LT2808325T (lt) Pakeistieji azolai, antivirusinis aktyvus ingredientas, farmacinė kompozicija, jų gavimo ir panaudojimo būdas
CL2013000337A1 (es) Composicion insecticida ternaria que comprende un compuesto piretroide, un neonicotinoide y un compuesto de benzoil-fenil urea en una cantidad sinérgicamente eficaz; metodo para el control de insectos que comprende el uso de dicha composicion.
EP3932917A3 (en) Substituted phenyloxazolidinones for antimicrobial therapy
WO2012146980A3 (en) Preparation of fingolimod and its salts
MX2013008197A (es) Sales de aminas organicas de azilsartan, metodo de preparacion y uso de las mismas.
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
BR112015022207A2 (pt) forma cristalina do composto i, formas cristalinas de sais do composto i e método para o tratamento de melanoma
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
JP2014520657A5 (enExample)
UY34647A (es) Composiciones farmacéuticas